Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,338,874

« Back to Dashboard

Patent 5,338,874 protects ELOXATIN and is included in two NDAs. There have been four Paragraph IV challenges on Eloxatin. There are four tentative approvals for the compound protected by this patent. Additional details are available via the generic ingredient links below.

Protection for ELOXATIN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 5,338,874

Title: Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity
Abstract:Disclosed herein is cis-oxalato (trans-1-1,2-cyclohexanediamine) Pt(II) optically high purity. Because of its complete optical purity, the compound is effective as raw material of such a medicine as a carcinostatic agent. The complete optical purity of the above compound may be proved by comparing the respective melting points of the cis-oxalato (trans-1-1,2-cyclohexanediamine).
Inventor(s): Nakanishi; Chihiro (Kanagawa, JP), Ohnishi; Yuko (Kanagawa, JP), Ohnishi; Junji (Kanagawa, JP), Taniuchi; Junichi (Kanagawa, JP), Okamoto; Koji (Kanagawa, JP), Tozawa; Takeshi (Kanagawa, JP)
Assignee: Tanaka Kikinzoku Kogyo K.K. (JP)
Application Number:08/043,901
Patent Claim Types:
see list of patent claims
Compound;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi Aventis Us
ELOXATIN
oxaliplatin
INJECTABLE;IV (INFUSION)021492Aug 9, 2002DISCNNo5,338,874*PED<disabled>
Sanofi Aventis Us
ELOXATIN
oxaliplatin
INJECTABLE;IV (INFUSION)021759Jan 31, 2005RXYes5,338,874*PED<disabled>
Sanofi Aventis Us
ELOXATIN
oxaliplatin
INJECTABLE;IV (INFUSION)021759Nov 17, 2006RXYes5,338,874*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,338,874

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan5-019508Jan 12, 1993

International Patent Family for Patent: 5,338,874

Country Document Number Publication Date
United States of America5298642Mar 29, 1994
Japan6211883Aug 02, 1994
Japan2673331Nov 05, 1997
Japan6287021Oct 11, 1994
Spain2125320Mar 01, 1999
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc